RecruitingNot applicableNCT06584123

Molecular Pituitary Imaging Using 18F-FET PET

Studying Functioning pituitary adenoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Cambridge
Principal Investigator
Mark Gurnell, MD, PhD
Cambridge University Hospitals NHS Foundation Trust
Intervention
18F-Fluoro-ethyl-tyrosine (FET) PET(diagnostic_test)
Enrollment
20 enrolled
Eligibility
18-100 years · All sexes
Timeline
2024 – 2026

Study locations (1)

Collaborators

Cambridge University Hospitals NHS Foundation Trust

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06584123 on ClinicalTrials.gov

Other trials for Functioning pituitary adenoma

Additional recruiting or active studies for the same condition.

See all trials for Functioning pituitary adenoma →

← Back to all trials